Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innospec (IOSP) Shares Outstanding (Diluted Average) (2017 - 2022)

Innospec (IOSP) has disclosed Shares Outstanding (Diluted Average) for 9 consecutive years, with $25.0 million as the latest value for Q4 2022.

  • Quarterly Shares Outstanding (Diluted Average) rose 0.52% to $25.0 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $25.0 million through Dec 2022, up 0.52% year-over-year, with the annual reading at $25.0 million for FY2022, 0.52% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $25.0 million in Q4 2022 for Innospec, roughly flat from $25.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $25.0 million in Q4 2022 to a low of $24.6 million in Q2 2020.
  • Historically, Shares Outstanding (Diluted Average) has averaged $24.8 million across 5 years, with a median of $24.8 million in 2020.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): decreased 0.46% in 2020 and later rose 1.24% in 2021.
  • Year by year, Shares Outstanding (Diluted Average) stood at $24.6 million in 2018, then increased by 0.51% to $24.7 million in 2019, then rose by 0.21% to $24.8 million in 2020, then grew by 0.3% to $24.9 million in 2021, then increased by 0.52% to $25.0 million in 2022.
  • Business Quant data shows Shares Outstanding (Diluted Average) for IOSP at $25.0 million in Q4 2022, $25.0 million in Q3 2022, and $25.0 million in Q2 2022.